$428.59
2.72% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US45168D1046
Symbol
IDXX
Sector

IDEXX Laboratories Target price 2024 - Analyst rating & recommendation

IDEXX Laboratories Classifications & Recommendation:

Buy
40%
Hold
47%
Sell
13%

IDEXX Laboratories Price Target

Target Price $495.30
Price $428.59
Potential 15.57%
Number of Estimates 10
10 Analysts have issued a price target IDEXX Laboratories 2025 . The average IDEXX Laboratories target price is $495.30. This is 15.57% higher than the current stock price. The highest price target is $566.00 32.06% , the lowest is $435.00 1.50% .
A rating was issued by 15 analysts: 6 Analysts recommend IDEXX Laboratories to buy, 7 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the IDEXX Laboratories stock has an average upside potential 2025 of 15.57% . Most analysts recommend the IDEXX Laboratories stock at Hold.

Sales and Margin forecast 2024, 2025 to 2027


Dec '23 2024
Estimates
Revenue Billion $ 3.66 3.88
8.72% 5.92%
EBITDA Margin 32.98% 33.40%
12.37% 1.27%
Net Margin 22.54% 22.11%
15.23% 1.92%

10 Analysts have issued a sales forecast IDEXX Laboratories 2024 . The average IDEXX Laboratories sales estimate is $3.9b . This is 0.85% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $3.9b 1.02% , the lowest is $3.9b 0.70% .

This results in the following potential growth metrics:

Revenue Estimates

2023 $3.7b 8.72%
2024 $3.9b 5.92%
2025 $4.1b 6.81%
2026 $4.5b 8.53%
2027 $4.9b 8.62%

7 Analysts have issued an IDEXX Laboratories EBITDA forecast 2024. The average IDEXX Laboratories EBITDA estimate is $1.3b . This is 4.59% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $1.4b 11.32% , the lowest is $1.2b 0.25% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $1.2b 22.17%
2024 $1.3b 7.26%
2025 $1.4b 10.15%
2026 $1.5b 8.35%
2027 $1.7b 10.28%

EBITDA Margin

2023 32.98% 12.37%
2024 33.40% 1.27%
2025 34.44% 3.11%
2026 34.38% 0.17%
2027 34.91% 1.54%

11 IDEXX Laboratories Analysts have issued a net profit forecast 2024. The average IDEXX Laboratories net profit estimate is $857m . This is 0.87% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $864m 1.64% , the lowest is $853m 0.39% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $825m 25.28%
2024 $857m 3.88%
2025 $981m 14.41%
2026 $1.1b 13.13%
2027 $1.3b 13.63%

Net Margin

2023 22.54% 15.23%
2024 22.11% 1.92%
2025 23.68% 7.10%
2026 24.69% 4.27%
2027 25.83% 4.62%

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027


Dec '23 2024
Estimates
Earnings Per Share $ 10.06 10.45
25.28% 3.88%
P/E 41.01
EV/Sales 9.23

11 Analysts have issued a IDEXX Laboratories forecast for earnings per share. The average IDEXX Laboratories <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $10.45 . This is 0.87% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $10.53 1.64% , the lowest is $10.40 0.39% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $10.06 25.28%
2024 $10.45 3.88%
2025 $11.96 14.45%
2026 $13.53 13.13%
2027 $15.37 13.60%

P/E ratio

Current 41.35 15.25%
2024 41.01 0.82%
2025 35.85 12.58%
2026 31.69 11.60%
2027 27.88 12.02%

Based on analysts' sales estimates for 2024, the IDEXX Laboratories stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 9.23 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 9.05 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 9.31 17.54%
2024 9.23 0.88%
2025 8.64 6.38%
2026 7.96 7.86%
2027 7.33 7.93%

P/S ratio

Current 9.13 17.53%
2024 9.05 0.85%
2025 8.47 6.38%
2026 7.81 7.86%
2027 7.19 7.93%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today